Artificial Intelligence

With the emergence of generative artificial intelligence tools, organizations have new opportunities to drive growth and innovation. However, without the proper policies, protections, and safeguards, they risk the loss of intellectual property and other business harms. MBHB has the knowledge and experience to help organizations safeguard innovations and avoid pitfalls.

Leadership

Foster growth and minimize risk with expert AI legal counsel

MBHB advises clients across technologies, including in the high tech, life sciences, manufacturing, and medical device fields, to help them leverage AI (including generative AI tools) in a safe and compliant manner. Our experienced team has been working on AI-related IP issues for more than 15 years to protect assets and mitigate risks in a dynamic environment marked by rapid advancements in technology.

We have been involved in AI from the start. Our attorneys and agents secured patents for machine learning technologies and assisted in generative AI projects well before the latest large language models took the world by storm. Today, we work to obtain and enforce IP rights for generative AI-related tools and systems and to ensure that confidential information is protected from leaking through use of AI.

Broad experience in AI

In addition to securing IP rights for AI innovations, we have created policies and guidelines around the use of AI. We work closely with clients to create functional AI usage policies that help them protect IP and safeguard valuable company data and information.

46%
of American companies have saved between $25,000 and $70,000 by using ChatGPT according to recent surveys.

Legal guidance from the front lines of AI innovation

MBHB attorneys are actively engaged in discussions about issues related to AI technologies and are sought out for their expertise on AI-related law. As a result, we are well-positioned to counsel clients through all stages of AI-related development.

We provide support throughout the product lifecycle, from innovation to commercialization and beyond. We counsel clients on how to respond effectively to new developments and properly navigate the use of AI within their own organizations, while maintaining focus on business goals.

Subscribe

Get all the latest updates on the biotechnology and pharmaceutical industry
Search
Menu
Menu